Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gum Tech

This article was originally published in The Tan Sheet

Executive Summary

Former Perrigo VP-Commercial Development Carl Johnson named president, drug delivery technology firm announces July 18. Johnson was responsible for private labeler's procurement of new products, technologies and contract manufacturing services. He also spent 15 years at J&J, directing national launch of Acuvue disposable contact lenses. Johnson succeeds Gary Kehoe, who became a Wrigley Healthcare employee upon the July 20 closing of its purchase of Gum Tech's gum manufacturing operations (1"The Tan Sheet" March 19, In Brief)

You may also be interested in...



Wrigley

Healthcare division has signed a $25 mil. agreement to acquire complete assets of Gum Tech's gum business, firm announces March 15. Under the deal, Wrigley will obtain rights to Gum Tech's manufacturing facility and plant as well as existing manufacturing contracts. Gum Tech will retain its interest in Gel Tech and its joint venture with Swedish Match. Wrigley said the acquisition will enable its new healthcare division to more quickly and cost effectively develop innovative products than it would have by building its own facility. Wrigley Healthcare began shipping Surpass antacid chewing gum, its first OTC product, Feb. 19 (1"The Tan Sheet" Feb. 19, p. 8)

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

OM006051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel